Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  NEW ZEALAND STOCK EXCHANGE  >  A2 Milk Company Ltd    ATM   NZATME0002S8


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Caution Required For Formula And Supplements

share with twitter share with LinkedIn share with facebook
share via e-mail
09/24/2019 | 08:00pm EST

Common themes exist for a2 Milk, Bubs Australia and Blackmores in their exposure to Chinese demand, and Wilsons sounds out the market while initiating coverage of the three.

-Niche infant formula products with functional benefits best positioned for growth in China
-Continued product development in supplements segment required
-Cost of doing business increasing in China for foreign brands


The revenue potential for infant formula and, more broadly, food & beverages in China, has been well flagged, although Wilsons suggests caution is warranted given the changes to Chinese sales channels and associated costs.

The broker initiates coverage on a2 Milk ((A2M)) with a Hold rating and $12.08 target, Bubs Australia ((BUB)), with a Hold rating and $1.30 target, and Blackmores ((BKL)) with a Sell rating and $70.30 target, in this sector.

Wilsons notes some common themes across the three, given their exposure to Chinese demand. A2 Milk is well-positioned to capitalise on the infant formula opportunity as it has a niche product, strong brand awareness and regulatory registration.

Nevertheless, the near-term warrants caution as the more direct distribution model in China is accentuated by uncertainty around the returns available from increased marketing expenditure.

Meanwhile, Bubs Australia is an emerging brand with significant potential, in the broker's view, as it has a niche product and multiple distribution alliances. However, the risk profile is elevated as brand recognition is being built.

While there is strong brand awareness of Blackmores the growth profile is challenged by China's regulatory structure which limits the company's prospects outside of online business, and there is heightened competition in food supplements.

The broker believes a2 Milk is the best positioned of the local brands to capitalise on the opportunity in China as it has multiple points of access to the consumer. The broker is less certain about Blackmores as its main channel, cross-border e-commerce, is being disrupted. The broker also considers the current share price excessive for the outlook.

Demographic Indicators

A declining birth rate in China since 2016 is the key headwind for infant formula demand and cost of living in major cities continues to be high relative to average income. Hence, the introduction of the two-child policy, while encouraging for the industry, may not be as significant as it appears.

In contrast, an ageing population provides the impetus for vitamins, minerals and supplement purchases, and the percentage of people above the age of 40 has increased to 48% in China over the last two decades from 31%.

While premium products feature as China's middle-class grows, the fact they are imported is no considered longer sufficient. Hence, Wilsons believes niche infant formula products with functional benefits, such as a2 Milk's product and goats milk are the best positioned.

A2 Milk sourcing is largely from Australasia. A2 milk is from dairy cows that are genetically tested for producing milk that only includes the A2 type of beta casein. Supply, particularly out of New Zealand, has increased substantially over the last five years.

The broker points out Europe has the most developed dairy goat sector and the Netherlands and Germany are major exporters of the milk. Australasia remains the next logical candidate with a "reasonable" goat dairy industry. However, there are constraints around supply of goats milk, as production per goat is significantly lower than per cow.

Product development is key for the supplements industry, which has a less sticky consumer profile. The broker cites the recent emergence of edible supplements that have functional benefits such as "anti ageing" as a fast-growing segment.

Wilsons also points out the Australian supplements industry has a higher cost base versus offshore peers, as Australia is the only country where manufacturers are required to produce to a pharmaceutical standard and certified for good manufacturing practice.


China has instigated increased scrutiny on social e-commerce and, in infant formula, the re-emergence of channels outside of the online segment and expansion in lower-tier cities are likely to be the next drivers of growth, in the broker's view.

Most of the conversion to online purchasing has now occurred and competition amongst e-commerce platforms has intensified. This highlights the importance of China's SAMR (State Administration for Market Regulation), which is required for infant formula sales.

The broker believes foreign infant formula brands that have an integrated channel approach are likely to be the most successful and "Mother and Baby" stores remain the dominant channel for the category. In this regard, the supplements industry does not have the same growth opportunities outside of online business because of a lack of consumer trust and the regulatory complexity.

Cross-border e-commerce remains the more important channel for foreign supplement brands. The broker suspects the supplements industry will go through a similar period of reforms to that which ensued for the infant formula industry in 2016/17 culminating in the introduction of SAMR.

The cost of doing business in China for foreign brands is also increasing along with heightened competition, especially for those mature brands transitioning from the low-cost daigou (product purchased outside China for sale in China) to a more direct distribution.

Wilsons assesses small daigous will fade out or consolidate into social e-commerce platforms because of low profitability and regulatory hurdles and the larger corporate daigous will need to partner with the platforms to stay compliant with the new rules.

FNArena is proud about its track record and past achievements: Ten Years On

All material published by FN Arena is the copyright of the publisher, unless otherwise stated. Reproduction in whole or in part is not permitted without written permission of the publisher.

© 2019 Acquisdata Pty Ltd., source FN Arena

Stocks mentioned in the article
ChangeLast1st jan.
A2 MILK COMPANY LTD End-of-day quote.
BLACKMORES LIMITED 0.82% 87.19 End-of-day quote.1.98%
BUBS AUSTRALIA LIMITED 0.00% 0.945 End-of-day quote.-3.57%
THE A2 MILK COMPANY LIMITED 2.41% 10.19 Delayed Quote.-0.68%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on A2 MILK COMPANY LTD
2019A2 MILK : New Zealand's a2 Milk Reaffirms Guidance, Strategy After CEO Quits
2019A2 MILK : CEO of New Zealand's a2 Milk Resigns, Interim Chief Named
2019DAVID HEARN : Safestore Holdings Appoints David Hearn as Chairman From January
2019A2 MILK : Market Expected to Attain an Estimated Value of USD 18.1 billion by 20..
2019A2 MILK : Change in substantial holding
2019A2 MILK : Growth And Challenges Ahead For a2 Milk
2019Australian shares extend falls; weak China data weighs on market
2019Caution Required For Formula And Supplements
2019A2 MILK : Ord Minnett rates A2M as Lighten
2019Diversity Paramount For Synlait Milk
More news
Financials (NZD)
Sales 2020 1 665 M
EBIT 2020 488 M
Net income 2020 344 M
Finance 2020 790 M
Yield 2020 -
P/E ratio 2020 32,9x
P/E ratio 2021 26,7x
EV / Sales2020 6,27x
EV / Sales2021 5,03x
Capitalization 11 222 M
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 15,39  NZD
Last Close Price 15,16  NZD
Spread / Highest target 15,4%
Spread / Average Target 1,53%
Spread / Lowest Target -24,1%
EPS Revisions
Geoffrey Howard Babidge Chief Executive Officer
David Lovat Hearn Chairman
Shareef Khan Chief Operations Officer
Strauss Race Chief Financial Officer
Julia Cecile Hoare Deputy Chairman